Cargando…
Application of Liquid Biopsies in Cancer Targeted Therapy
As a growing body of evidence demonstrates intertumoral and intratumoral heterogeneity and clonal evolution, both during carcinogenesis and also throughout treatment resulting in acquired drug resistance, the utility of blood‐based assays or “liquid biopsies” is becoming increasingly recognized in c...
Autores principales: | Sumanasuriya, S, Lambros, MB, de Bono, JS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655895/ https://www.ncbi.nlm.nih.gov/pubmed/28755443 http://dx.doi.org/10.1002/cpt.764 |
Ejemplares similares
-
HER3 Is an Actionable Target in Advanced Prostate Cancer
por: Gil, Veronica, et al.
Publicado: (2021) -
Clinical validation of a spectroscopic liquid biopsy for earlier detection of brain cancer
por: Cameron, James M, et al.
Publicado: (2022) -
Targeted Transcriptional Profiling of Kidney Transplant Biopsies
por: Sigdel, Tara K., et al.
Publicado: (2018) -
Clinical Application of Liquid Biopsy in Targeted Therapy of Metastatic Colorectal Cancer
por: Trojan, Jörg, et al.
Publicado: (2017) -
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer
por: Ring, Alexander, et al.
Publicado: (2022)